Psychiatry · Roselle, NJ
NPI
1275529356
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
301 Cox St
Roselle, NJ, 07203
Phone (908) 241-7200
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.6M
6,454 prescriptions
Company payments, 2025
$2,174
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Vicente M Lim prescribed most often to Medicare patients was Benztropine Mesylate, with 463 prescriptions and refills. In total Vicente M Lim wrote 6,454 Medicare prescriptions that cost $6.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 463 | 502 | 56 | $6,102 |
| Risperidone Generic | 451 | 491 | 45 | $6,085 |
| Invega Sustenna Paliperidone Palmitate | 400 | 427 | 50 | $1.3M |
| Olanzapine Generic | 282 | 296 | 25 | $12K |
| Lorazepam Generic | 244 | 252 | 33 | $1,854 |
| Divalproex Sodium Er Divalproex Sodium | 182 | 204 | 23 | $19K |
| Austedo Deutetrabenazine | 176 | 176 | 18 | $942K |
| Trazodone Hcl Generic | 176 | 181 | 28 | $1,528 |
| Vraylar Cariprazine Hcl | 152 | 186 | 20 | $258K |
| Haloperidol Generic | 143 | 151 | 15 | $7,086 |
| Quetiapine Fumarate Generic | 136 | 142 | 15 | $2,561 |
| Fluoxetine Hcl Generic | 134 | 140 | 12 | $1,203 |
| Vivitrol Naltrexone Microspheres | 132 | 172 | 24 | $271K |
| Lybalvi Olanzapine/Samidorphan Malate | 129 | 176 | 17 | $259K |
| Mirtazapine Generic | 125 | 129 | 12 | $1,684 |
Brand drugs: 1,993 claims; generic drugs: 4,449 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vicente M Lim $2,174 ($2,174 in general payments such as food, travel and fees) from 10 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $391.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 26 | $391 |
| Neurocrine BioSciences, Inc. NBIX | 23 | $352 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 21 | $341 |
| Abbvie Inc. ABBV | 15 | $218 |
| Alkermes, Inc. ALKS | 11 | $199 |
| Luye Pharma (USA) Ltd. 2186.HK | 14 | $191 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $181 |
| Janssen Pharmaceuticals, Inc JNJ | 10 | $160 |
| Lundbeck LLC | 5 | $85.81 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $55.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.